OncoQuest Pharmaceuticals Inc Asset Resilience Ratio
OncoQuest Pharmaceuticals Inc asset resilience ratio. OncoQuest Pharmaceuticals Inc (078590) has an Asset Resilience Ratio of 17.73% as of March 2026. The Asset Resilience Ratio measures the percentage of a company's total assets that are held in liquid form (cash and short-term investments). This metric indicates how well-positioned the company is to handle unexpected financial challenges, economic downturns, or strategic opportunities without requiring external financing. See 078590 defensive interval ratio to measure how many days the company can operate on defensive assets alone.
Liquid Assets
Total Assets
Resilience Assessment
Asset Resilience Ratio of OncoQuest Pharmaceuticals Inc (2022–2025)
Asset resilience ratio of OncoQuest Pharmaceuticals Inc from 2022 to 2025. This chart shows how OncoQuest Pharmaceuticals Inc's Asset Resilience Ratio has changed over time. Read OncoQuest Pharmaceuticals Inc total liabilities for a breakdown of total debt and financial obligations.
Liquid Assets Composition Over Time
This chart breaks down OncoQuest Pharmaceuticals Inc's liquid assets into cash & equivalents and short-term investments, showing how the composition has evolved over time. For the complete balance sheet picture, see 078590 asset base.
Current Liquid Assets Breakdown
| Component | Amount | % of Total Assets |
|---|---|---|
| Cash & Equivalents | ₩0.00 | 0% |
| Short-term Investments | ₩16.72 Billion | 17.73% |
| Total Liquid Assets | ₩16.72 Billion | 17.73% |
Asset Resilience Insights
- Good Liquidity Position: OncoQuest Pharmaceuticals Inc maintains a healthy 17.73% of assets in liquid form.
- This level provides good financial flexibility while maintaining productive asset deployment.
- The company has significant short-term investments, indicating active treasury management.
OncoQuest Pharmaceuticals Inc Industry Peers by Asset Resilience Ratio
Compare OncoQuest Pharmaceuticals Inc's asset resilience ratio with other companies in the same industry.
| Company | Industry | Asset Resilience Ratio |
|---|---|---|
| No industry peers found with asset resilience data. | ||
OncoQuest Pharmaceuticals Inc Asset Resilience Ratio by Year (2022–2025)
OncoQuest Pharmaceuticals Inc asset resilience ratio by year from 2022 to 2025. The table below shows the annual Asset Resilience Ratio data for OncoQuest Pharmaceuticals Inc.
| Year | Asset Resilience Ratio (%) | Liquid Assets | Total Assets | Change |
|---|---|---|---|---|
| 2025-12-31 | 11.26% | ₩9.19 Billion ≈ $6.23 Million |
₩81.61 Billion ≈ $55.30 Million |
+1.79pp |
| 2024-12-31 | 9.47% | ₩7.13 Billion ≈ $4.83 Million |
₩75.31 Billion ≈ $51.04 Million |
-21.92pp |
| 2023-12-31 | 31.39% | ₩17.01 Billion ≈ $11.53 Million |
₩54.19 Billion ≈ $36.73 Million |
-24.30pp |
| 2022-12-31 | 55.69% | ₩24.52 Billion ≈ $16.61 Million |
₩44.02 Billion ≈ $29.83 Million |
-- |
About OncoQuest Pharmaceuticals Inc
DIAC Co., Ltd. engages in the car interior and exterior materials business in South Korea and internationally. DIAC Co., Ltd. was founded in 1993 and is headquartered in Miryang-si, South Korea.